Gadolinio y fibrosis nefrogénica sistémica.

Introduction: Nephrogenic systemic fibrosis (NSF), is a disease characterized by its predominant cutaneous findings. In some patients there is a systemic involucrum; It was described for the first time in 1997. Methodology: This disease has been associated with a combination of factors including altered renal function, inflammatory processes and the exhibition to contrast agent based on Gadolinium. Gadolinium and nephrogenic systemic fibrosis: The mechanism through which contrast agents based on Gadolinium may trigger NFS is not completely well-known. However, the solid association between Gadolinium and NFS limits its use in patients with renal insufficiency. In this revision, the current situation of NFS, its association with the use of contrast agents containing Gadolinium and the recommendations proposed by different organizations, is shown. [ABSTRACT FROM AUTHOR]